These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20086217)

  • 21. Hormonal diagnosis of GH hypersecretory states.
    Grottoli S; Gasco V; Ragazzoni F; Ghigo E
    J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GHRH plus arginine in the diagnosis of acquired GH deficiency of childhood-onset.
    Maghnie M; Cavigioli F; Tinelli C; Autelli M; Aricò M; Aimaretti G; Ghigo E
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2740-4. PubMed ID: 12050243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Remission of Cushing's disease with growth hormone replacement.
    Öztürk M; Atmaca M
    Growth Horm IGF Res; 2011 Aug; 21(4):238-41. PubMed ID: 21641842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease.
    Acebes JJ; Martino J; Masuet C; Montanya E; Soler J
    Acta Neurochir (Wien); 2007; 149(5):471-7; discussion 477-9. PubMed ID: 17406780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term results of stereotactic radiosurgery in secretory pituitary adenomas.
    Castinetti F; Nagai M; Morange I; Dufour H; Caron P; Chanson P; Cortet-Rudelli C; Kuhn JM; Conte-Devolx B; Regis J; Brue T
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3400-7. PubMed ID: 19509108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MJA Practice Essentials--Endocrinology. 9: Pituitary disease in adults.
    Hurley DM; Ho KK
    Med J Aust; 2004 Apr; 180(8):419-25. PubMed ID: 15089738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypopituitarism in Cushing's disease.
    Cavagnini F; Scacchi M; Pecori Giraldi F
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):44-7. PubMed ID: 19020385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pituitary disorders during pregnancy.
    Motivala S; Gologorsky Y; Kostandinov J; Post KD
    Endocrinol Metab Clin North Am; 2011 Dec; 40(4):827-36. PubMed ID: 22108282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mortality in Cushing's disease.
    Clayton RN
    Neuroendocrinology; 2010; 92 Suppl 1():71-6. PubMed ID: 20829622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of protracted treatment with rosiglitazone, a PPARgamma agonist, in patients with Cushing's disease.
    Pecori Giraldi F; Scaroni C; Arvat E; Martin M; Giordano R; Albiger N; Leao AA; Picu A; Mantero F; Cavagnini F
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):219-24. PubMed ID: 16430724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative preparation of patients with pituitary gland disorders.
    Malenković V; Gvozdenović L; Milaković B; Sabljak V; Ladjević N; Zivaljević V
    Acta Chir Iugosl; 2011; 58(2):91-6. PubMed ID: 21879656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
    Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS
    Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pituitary tumours in African and Indian patients.
    Jialal I; Reddi K; Omar MA; Van Dellen JR; Joubert SM
    Trop Geogr Med; 1986 Jun; 38(2):175-9. PubMed ID: 3738985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maximizing the accuracy of Inferior petrosal sinus sampling: validation of the use of Prolactin as a marker of pituitary venous effluent in the diagnosis of Cushing's disease.
    Grant P; Dworakowska D; Carroll P
    Clin Endocrinol (Oxf); 2012 Apr; 76(4):555-9. PubMed ID: 22017348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New developments in pituitary diseases].
    Gruber M; Willenberg HS; Bornstein SR
    Dtsch Med Wochenschr; 2012 Dec; 137(49):2540-2. PubMed ID: 23188633
    [No Abstract]   [Full Text] [Related]  

  • 37. Pathophysiology of Cushing's disease.
    Fehm HL; Voigt KH
    Pathobiol Annu; 1979; 9():225-55. PubMed ID: 225710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pituitary disease mortality: is it fiction?
    Erfurth EM; Siesjö P; Björk-Eriksson T
    Pituitary; 2013 Sep; 16(3):402-12. PubMed ID: 23400812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of a met-enkephalin analog on adrenocorticotropin (ACTH), growth hormone, and prolactin in patients with ACTH hypersecretion.
    Allolio B; Winkelmann W; Hipp FX; Kaulen D; Mies R
    J Clin Endocrinol Metab; 1982 Jul; 55(1):1-7. PubMed ID: 6281297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas.
    Woo YS; Isidori AM; Wat WZ; Kaltsas GA; Afshar F; Sabin I; Jenkins PJ; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4963-9. PubMed ID: 15886242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.